Company News: Recent Data on Curetis’ Unyvero ITI Application Demonstrate its Clinical and Health Economic Benefits
– Several ECCMID 2017 presentations highlight advantages of rapid time to result with Unyvero ITI in Prosthetic Joint Infections
Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced the recent presentation of new data demonstrating the clinical and health economic benefits of using the Company’s Unyvero ITI (Implant and Tissue Infections) Application for the diagnosis of prosthetic joint infections. Data were presented during this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID, April 22-25, 2017, Vienna/Austria).
Company News: Heraeus Medical – New PALAMIX® vacuum mixing system for bone cement optimises organisation of orthopaedic surgery
— The innovative design of PALAMIX® allows a high degree of safety and convenience for both personnel and patients
More efficient organisation of hip and knee joint surgery for the medical staff and patients – these are just a few of the advantages of the new PALAMIX® vacuum mixing system from Heraeus Medical. The new generation makes mixing and application of bone cement even easier and more convenient for permanent anchorage of hip and knee joint prostheses.
– Product to launch in EMEA at ECCMID Conference
April 22-25, 2017
– IAI Panel covers up to 130 diagnostic targets
Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced the successful completion of clinical performance evaluation and CE-IVD marking of its fourth Unyvero Application Cartridge for the diagnosis of severe intra-abdominal infections (IAI).